Arrivent Biopharma

ArriVent Biopharma is a company based in Newtown Square, Pennsylvania, specializing in the development of biopharmaceutical products. Currently employing 40 people, ArriVent is a relatively small company with a revenue exceeding $10,000. ArriVent focuses on acquiring promising drug candidates from various development stages, particularly those originating from China and other emerging biotech centers. Their goal is to collaborate with innovative biopharma companies worldwide to bring these medicines to patients suffering from unmet medical needs, initially concentrating on oncology. ArriVent distinguishes itself through its extensive global network, enabling access to a diverse pool of cutting-edge drug candidates. Their commitment to strategic partnerships with innovative biopharma companies drives their mission to globalize access to life-changing treatments. For more information about ArriVent Biopharma and their innovative approach to biopharmaceutical development, visit their website at arrivent.com.